Approval of Aducanumab for Alzheimer Disease-the FDA's Perspective. Dunn B, Stein P, Cavazzoni P. JAMA Intern Med 2021 Jul 13. pii: 2782119. doi: 10.1001/jamainternmed.2021.4607.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Dunn B, Stein P, Cavazzoni P. Approval of Aducanumab for Alzheimer Disease-the FDA's Perspective. JAMA Intern Med 2021 Jul 13. pii: 2782119. doi: 10.1001/jamainternmed.2021.4607.
PMID: 34254984